Project Grant R15HL170359
- The National Institutes of Health's National Heart, Lung and Blood Institute awarded $2,350,623 under the Cardiovascular Diseases Research program (CFDA 93.837) to the Regents of the University of Minnesota on May 1, 2021 for a project concluding on April 30, 2022. The project aims to reduce childhood obesity through an individual randomized controlled trial testing combinations of ecological momentary intervention, home visiting, and video feedback delivered to 510 low-income, racially...
- This $3,690,570 Project Grant award from the National Institute of Nursing Research (NINR), under the Nursing Research federal grant program (CFDA 93.361), aims to improve obesity treatment among adults with food insecurity. The study will conduct a randomized controlled trial with 300 participants assigned to one of three groups: Behavioral Weight Loss (BWL) alone, BWL with food vouchers, or BWL with home-delivered, medically tailored groceries. The primary objective is to assess whether the...
- The National Heart, Lung, and Blood Institute (NHLBI), part of the National Institutes of Health (NIH), awarded a $766,920 Project Grant under the Cardiovascular Diseases Research (CFDA 93.837) program. The grant, effective May 15, 2025 through February 28, 2029, will support research by Augusta University Research Institute, Inc. (doing business as Georgia Health Sciences) to investigate the mechanisms linking skeletal muscle health and vascular function in obesity. The research aims to...
- The National Heart, Lung, and Blood Institute (NHLBI) awarded a $538,998 Project Grant to Texas A&M AgriLife Research under the Cardiovascular Diseases Research federal grant program (CFDA 93.837). The 4-year "Deep in the Heart" project aims to develop and evaluate a community-engaged intervention to prevent obesity and cardiovascular disease risk factors in rural South Texas women. The project will involve formative research, a multilevel intervention including group classes, a...
- This federal Project Grant award for $732,261 from the National Heart, Lung, and Blood Institute (NHLBI) under the Cardiovascular Diseases Research program (CFDA 93.837) supports research to identify central obesity genes and validate their function using in vitro and in vivo models. The project aims to leverage large-scale, multi-ethnic genomic and multi-omic data from nine longitudinal studies in the NHLBI Trans-Omics for Precision Medicine (TOPMed) program to pinpoint target genes that...
- The National Heart, Lung, and Blood Institute (NHLBI) awarded a $763,858 Project Grant under the Cardiovascular Diseases Research program (CFDA 93.837) to Brigham & Women's Hospital Inc. (a subsidiary of Partners Healthcare System Inc.) to assess the impact of improving cardiovascular disease (CVD) care for adults with diagnosed diabetes across diverse global settings. The project, led by Dr. Jennifer Manne-Goehler and an interdisciplinary team, aims to develop the PREDICT-DM global...
- This $237,750 Project Grant award from the National Heart, Lung, and Blood Institute (CFDA 93.837 Cardiovascular Diseases Research) to Temple University aims to investigate the impact of an equity-focused implementation strategy on participation and uptake of Universal School Meals (USM) among students at highest risk for food insecurity and obesity. The project seeks to build on the principal investigator's existing K01 award, utilizing a multi-method approach to determine if the equity-focused...
- This Project Grant award from the National Heart, Lung, and Blood Institute (CFDA 93.837 - Cardiovascular Diseases Research) provides $766,277 to the University of North Carolina at Chapel Hill to optimize dietary adherence in a mobile behavioral weight loss intervention for adults. The project aims to use an innovative factorial trial design to identify intervention components that can directly improve dietary adherence for participants who do not initially respond well to the standard...
- This federal Project Grant award of $169,020.00 was provided by the National Heart Lung and Blood Institute (NHLBI), which operates under the Cardiovascular Diseases Research federal grant program (CFDA 93.837). The grant supports research at the University of Pennsylvania investigating the impact of obesity and diabetes on coronary microvascular defects in heart failure with preserved ejection fraction (HFpEF). The research will use an animal model of HFpEF to compare the temporal progression...
- The National Heart, Lung, and Blood Institute awarded a $156,486 Project Grant under the Cardiovascular Diseases Research program (CFDA 93.837) to the University of Denver. The 5-year grant, running from July 2, 2025 to January 5, 2027, will support research examining the association between discrimination reported during pregnancy and cardiovascular disease risk in mothers 3-4 years postpartum. The study will use a prospective longitudinal design with a population of at least 200...
The National Heart, Lung, and Blood Institute (NHLBI), through the Cardiovascular Diseases Research federal grant program (CFDA 93.837), awarded a $432,585 Project Grant to Villanova University in Pennsylvania for the "BRAVE (Building Respect and Acceptance through Valuing Everybody) Study." This study aims to implement and evaluate a weight bias reduction intervention for nursing students using simulation with standardized participants living with obesity. The goal is to translate the intervention into measurable behavior changes that can reduce the weight bias experienced by patients. The award period runs from Aug 1, 2025 to Jul 31, 2028. This effort builds on the grantee's prior pilot research showing favorable improvements in nursing students' attitudes and beliefs toward individuals with obesity following a similar weight bias reduction intervention.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | $432.6k | 7/28/25 |